Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Participation Type:

HIVR4P Home

HIVR4P 2016 is made possible in part by the generous support of the American people through 1 R13 AI122959-01 from the National Institute of Allergy and Infectious Diseases (NIAID), and from the United States Agency for International Development (USAID). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services or USAID; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 sessions: 1 to 9 of 9
Round Table 01: What Is Sterilizing Immunity?
Factors that Impact on the Genotypic and Phenotypic Features of Heterosexually Transmitted Clade C Founder Viruses
Carolyn Williamson
University of Cape Town & NHLS, South Africa
Early Events in HIV-1 Infection: New Insight from the RV217 Early Capture Acute Infection Cohort
Gustavo Kijak
U.S. Military HIV Research Program, Walter Reed Army Insititute of Research, United States
Breakthrough Occult HIV Infections Despite Sustained Plasma Levels of Antiretroviral Drugs Delivered in Long-acting Formulations
Martina Kovarova
University of North Carolina at Chapel Hill, United States
Gp120 Signatures Determining HIV Infectivity Are Universal across Primate Lentiviruses
Mileidy Gonzalez
NCBI, NIH, United States
Neutralizing Antibody-mediated Protection against Mucosal SHIV Challenge Includes Systemic Clearance of Distal Virus
Dan Barouch
Beth Israel Deaconess Medical Center, United States
Round Table Discussion: What Is Sterilizing Immunity?
Carolyn Williamson
University of Cape Town & NHLS, South Africa
Gustavo Kijak
U.S. Military HIV Research Program, Walter Reed Army Insititute of Research, United States
Martina Kovarova
University of North Carolina at Chapel Hill, United States
Mileidy Gonzalez
NCBI, NIH, United States
Dan Barouch
Beth Israel Deaconess Medical Center, United States
from HIV Research for Prevention 2016 on 19 October 2016 15:30-17:00
Round Table 02: The PrEP Prevention Package: From Efficacy Studies to the Real World
Case Studies in PrEP Implementation: The Australian Expanded PrEP Implementation in Communities Study (EPIC-NSW)
Andrew Grulich
Kirby Institute, UNSW Australia, Australia
Pre-Exposure Prophylaxis (PrEP): NYC Implementation Strategy
Demetre Daskalakis
New York City Department of Health and Mental Hygiene, United States
Structural Interventions to Enhance PrEP Availability and Delivery
Nduku Kilonzo
National AIDS Control Council, Kenya
Key Populations and Young People Views and Experiences on PrEP. Messages for Advocacy
Matteo Cassolato
International HIV/AIDS Alliance
Round Table Discussion: The PrEP Prevention Package: From Efficacy Studies to the Real World
Andrew Grulich
Kirby Institute, UNSW Australia, Australia
Demetre Daskalakis
New York City Department of Health and Mental Hygiene, United States
Nduku Kilonzo
National AIDS Control Council, Kenya
Matteo Cassolato
International HIV/AIDS Alliance
from HIV Research for Prevention 2016 on 19 October 2016 15:30-17:00
Round Table 03: Combinations and Keys: The Complexities and Successes of Reaching the People Who Need It
HIV and Sex Workers: Challenges and Lessons for Scaling up Programmes
Sinead Delany-Moretlwe
University of the Witwatersrand, South Africa
Reaching Epidemic Control by 2030: Challenges and Opportunities for Adolescent Girls and Young Women in Kenya
Kawango Agot
Impact Research & Development Organization, Kenya
Finding the Right Fit: Combination HIV Prevention for Men Who Have Sex with Men
Hyman Scott
San Francisco Department of Public Health, United States
Understanding HIV Risk Among Transgender Women and Developing Interventions for this Vulnerable Population
Amy Johnson
Ann & Robert H. Lurie Childrens Hospital of Chicago, United States
The Complexities and Successes of Reaching the People Who Inject Drugs
John Brooks
Centers for Disease Control and Prevention, Division of HIV/AIDS Prevention, United States
Round Table Discussion: Combinations and Keys: The Complexities and Successes of Reaching the People Who Need It
Sinead Delany-Moretlwe
University of the Witwatersrand, South Africa
Kawango Agot
Impact Research & Development Organization, Kenya
Hyman Scott
San Francisco Department of Public Health, United States
Amy Johnson
Ann & Robert H. Lurie Childrens Hospital of Chicago, United States
John Brooks
Centers for Disease Control and Prevention, Division of HIV/AIDS Prevention, United States
from HIV Research for Prevention 2016 on 20 October 2016 08:30-10:00
Round Table 04: Getting It Right: The Journey from Discovery to Impact
When We Got It Right and When We Got It Wrong
Maggie Keane
International AIDS Vaccine Initiative, United States
From Research to Practice: Translating VMMC Market Research into Program Design and Implementation in Zimbabwe
Karin Hatzold
Population Services International, Zimbabwe
Female Condoms: The World's Second HIV Prevention Tool—Barriers to a Good Product Getting Promoted and Used
Anne Philpott
Department for International Development, United Kingdom
Planning for Delivery: The Power of Partnerships (PMTCT: Thailand experience)
Rangsima Lolekha
Thailand MOPH - U.S. CDC Collaboration, Thailand
Round Table Discussion: Getting It Right: The Journey from Discovery to Impact
Maggie Keane
International AIDS Vaccine Initiative, United States
Karin Hatzold
Population Services International, Zimbabwe
Anne Philpott
Department for International Development, United Kingdom
Rangsima Lolekha
Thailand MOPH - U.S. CDC Collaboration, Thailand
from HIV Research for Prevention 2016 on 20 October 2016 08:30-10:00
Round Table 01: Safer Sex in 2014: Has the Paradigm Shifted?
What Is Safer Sex in 2014? Understanding The Biology of HIV Prevention
James McIntyre
Anova Health Institute, Johannesburg, South Africa
Communicating About Safer Sex - What is Missing in the Dialogue?
Lebogang Ramafoko
Soul City Institute, Dunkeld, South Africa
Missing the Future is not an Option
Jim Pickett
AIDS Foundation of Chicago, Chicago, IL, United States
Nduku Kilonzo
LVCT, Kenya
Round Table Discussion: Safer Sex in 2014: Has the Paradigm Shifted?
James McIntyre
Anova Health Institute, Johannesburg, South Africa
Lebogang Ramafoko
Soul City Institute, Dunkeld, South Africa
Jim Pickett
AIDS Foundation of Chicago, Chicago, IL, United States
Nduku Kilonzo
LVCT, Kenya
from HIV Research for Prevention 2014 on 29 October 2014 15:30-17:00
Round Table 02: Prevention of Mother-to-Child Transmission Revisited
The Role of PMTCT and Very Early Treatment in the Elimination of Pediatric HIV Infection
Sarah Read
NIAID, Rockville, MD, United States
The Case for Early Antiretroviral Treatment towards HIV Cure in Perinatal Infection
Deborah Persaud
Johns Hopkins University School of Medicine, Baltimore, MD, United States
Prevention of Mother‐to‐Child Transmission Revisited
Louise Kuhn
Columbia University, New York, NY, United States
PMTCT: Mind the Gaps!
Lee Fairlie
Wits RHI, Johannesburg, South Africa
Wrap Up - Prevention of Mother-to-Child Transmission
Coleen K. Cunningham
Duke University Medical Center, Durham, NC, USA
Round Table Discussion: Prevention of Mother-to-Child Transmission Revisited
Sarah Read
NIAID, Rockville, MD, United States
Deborah Persaud
Johns Hopkins University School of Medicine, Baltimore, MD, United States
Louise Kuhn
Columbia University, New York, NY, United States
Lee Fairlie
Wits RHI, Johannesburg, South Africa
Coleen K. Cunningham
Duke University Medical Center, Durham, NC, USA
from HIV Research for Prevention 2014 on 29 October 2014 15:30-17:00
Round Table 03: Diffusion of Innovation: Accelerating Along the Research to Rollout Continuum
HIV Prevention: Moving from Evidence to Demonstration Projects to Policy and Programs
Connie Celum
University of Washington, Seattle, WA, United States
Rapid rapid-scale-up of VMMC
Dirk Taljaard
CHAPS, Johannesburg, South Africa
Challenges for Prep Implementation in the US
Keith Rawlings
Gilead Sciences, Foster City, CA, United States
From Research Result to Public Health Impact: What Have we Learned and how Can we Do it Better and Faster
Mitchell Warren
AVAC, New York, NY, United States
Round Table Discussion: Diffusion of Innovation: Accelerating Along the Research to Rollout Continuum
Connie Celum
University of Washington, Seattle, WA, United States
Dirk Taljaard
CHAPS, Johannesburg, South Africa
Keith Rawlings
Gilead Sciences, Foster City, CA, United States
Mitchell Warren
AVAC, New York, NY, United States
from HIV Research for Prevention 2014 on 30 October 2014 15:30-17:00
Round Table 04: Research Where and With Whom it Matters
MSM: Long Road to Trial Participation in Africa
Eduard Sanders
KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
We are not Guinea Pigs: HIV Clinical Research for Smarties
Udom Likhitwonnawut
AVAC, Chiang Mai, Thailand
Fareed Abdullah
The South African National AIDS Council, South Africa
Engaging Adolescents and Young Adults in HIV Prevention Trials
Sybil Hosek
Stroger Hospital of Cook County, Chicago, IL, United States
African Couples Testing Matters: Most Transmissions Are in Marriage, Most Pregnancies Are Not Immaculate Conceptions, and Women ArenĀ“t Just Incubators
Susan Allen
Rwanda Zambia HIV Research Group-Emory University, Atlanta, GA, United States
Round Table Discussion: Research Where and With Whom it Matters
Eduard Sanders
KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Udom Likhitwonnawut
AVAC, Chiang Mai, Thailand
Fareed Abdullah
The South African National AIDS Council, South Africa
Sybil Hosek
Stroger Hospital of Cook County, Chicago, IL, United States
Susan Allen
Rwanda Zambia HIV Research Group-Emory University, Atlanta, GA, United States
from HIV Research for Prevention 2014 on 30 October 2014 15:30-17:00
Round Table 05: Multipurpose Technologies
MPTs: What Are they, and Why Are they Needed?
Judy Manning
US Agency for International Development, Washington, DC, United States
State of the Art: Multipurpose Prevention Technology Science and Product Development
Joseph Romano
NWJ Group, LLC, Wayne, PA, United States
Regulatory Considerations with Developing Combination Products
Charu Mullick
Food and Drug Administration, Silver Spring, MD, United States
Study Designs for Evaluating the Effectiveness of Multipurpose Technologies
Elizabeth Brown
Fred Hutchinson Cancer Research Center, Seattle, WA, United States
Multipurpose Prevention Technology
Elizabeth Bukusi
KEMRI, Nairobi, Kenya
Round Table Discussion: Multipurpose Technologies
Judy Manning
US Agency for International Development, Washington, DC, United States
Joseph Romano
NWJ Group, LLC, Wayne, PA, United States
Charu Mullick
Food and Drug Administration, Silver Spring, MD, United States
Elizabeth Brown
Fred Hutchinson Cancer Research Center, Seattle, WA, United States
Elizabeth Bukusi
KEMRI, Nairobi, Kenya
from HIV Research for Prevention 2014 on 31 October 2014 08:30-10:00
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 sessions: 1 to 9 of 9